Randomized controlled pilot study of the clinical efficacy of the Mika App
Phase 4
- Conditions
- C51-C58Malignant neoplasms of female genital organs
- Registration Number
- DRKS00023791
- Lead Sponsor
- Fosanis GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 70
Inclusion Criteria
possession of a smartphone
- diagnosed carcinoma (ovary, endometrium, cervix)
- German speaking
Exclusion Criteria
- no secured diagnosis of carcinoma
- not able to give informed consent
- diagnosis more than 5 years ago
-lack of smartphone or tablet skills
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method